Long noncoding RNA SNHG16 induces sorafenib resistance in hepatocellular carcinoma cells through sponging miR-140-5p

BACKGROUND: Sorafenib is widely used for treatment of hepatocellular carcinoma (HCC), but the acquired resistance remains a major obstacle for its application. Thus it is of critical importance to elucidate the molecular mechanisms underlying sorafenib resistance in HCC. This study aimed to determin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Junfeng, Zhang, Ruoyan, Du, Xiaohong, Chai, Wengang, Zhou, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324603/
https://www.ncbi.nlm.nih.gov/pubmed/30655679
http://dx.doi.org/10.2147/OTT.S175176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324603/
https://www.ncbi.nlm.nih.gov/pubmed/30655679
http://dx.doi.org/10.2147/OTT.S175176

Ejemplares similares